Evidence map›Paper›PMID 35200537›Full record

ReviewCurrent oncology (Toronto, Ont.)2022

Case Report of Small Cell Carcinoma of the Ovary, Hypercalcemic Type (Ovarian Rhabdoid Tumor) with

Maria Fernanda Evangelista Simões, Alexandre André Balieiro Anastácio da Costa, Tullio Novaes Silva, Lizieux Fernandes, Graziele Bovolim, Giovana Tardin Torrezan, Dirce Maria Carraro, Glauco Baiocchi, Ademir Narcizo Oliveira Menezes, Elizabeth Santana Dos Santos and 1 more

Open access · goldAbstract readCase ReportsReview
In one paragraph

Review in Current oncology (Toronto, Ont.), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Review
  12. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Maria Fernanda Evangelista SimõesAC Camargo Cancer Center, São Paulo 01000-000, Brazil.
Alexandre André Balieiro Anastácio da CostaAC Camargo Cancer Center, São Paulo 01000-000, Brazil.ORCID 0000-0002-1631-0105
Tullio Novaes SilvaAC Camargo Cancer Center, São Paulo 01000-000, Brazil.
Lizieux FernandesAC Camargo Cancer Center, São Paulo 01000-000, Brazil.
Graziele BovolimAC Camargo Cancer Center, São Paulo 01000-000, Brazil.
Giovana Tardin TorrezanAC Camargo Cancer Center, São Paulo 01000-000, Brazil.ORCID 0000-0002-8659-5329
Dirce Maria CarraroAC Camargo Cancer Center, São Paulo 01000-000, Brazil.
Glauco BaiocchiAC Camargo Cancer Center, São Paulo 01000-000, Brazil.ORCID 0000-0002-8193-5582
Ademir Narcizo Oliveira MenezesAC Camargo Cancer Center, São Paulo 01000-000, Brazil.
Elizabeth Santana Dos SantosAC Camargo Cancer Center, São Paulo 01000-000, Brazil.ORCID 0000-0002-2038-4668
Louise De BrotAC Camargo Cancer Center, São Paulo 01000-000, Brazil.ORCID 0000-0002-0551-4401
AC Camargo Hospital · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Small cell carcinoma of the ovary, hypercalcemic type (SCCOHT) is a rare and aggressive condition that is associated with the

Indexed as

Carcinoma, Small CellLung NeoplasmsOvarian NeoplasmsRhabdoid TumorSMARCB1 ProteinDNA HelicasesFatal OutcomeFemaleHumansMutationNuclear ProteinsOvaryTranscription FactorsDNA HelicasesNuclear ProteinsSMARCA4 protein, humanSMARCB1 ProteinSMARCB1 protein, humanTranscription Factorshypercalcemic typeovarian cancersmall cell carcinoma of the ovarySMARCB1 mutation

Identifiers

PMID35200537
PMCPMC8870484
OpenAlexW4205384952

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.